Athersys Reports Third Quarter 2016 Results
Nov 09, 2016 21:03 pm UTC| Business
CLEVELAND, Nov. 09, 2016 -- Athersys, Inc. (NASDAQ:ATHX) today announced its financial results for the three months ended September 30, 2016. Highlights of the third quarter of 2016 and recent events include: ...
Immune Design Reports Third Quarter 2016 Financial Results and Provides Corporate Update
Nov 09, 2016 21:02 pm UTC| Business
SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 09, 2016 -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, today reported financial results and a corporate update for the third...
TPI Composites Expands its Relationship with Nordex in Turkey
Nov 09, 2016 21:02 pm UTC| Business
SCOTTSDALE, Ariz., Nov. 09, 2016 -- TPI Composites, Inc., (TPI) (Nasdaq:TPIC), the largest U.S.-based independent manufacturer of composite wind blades, announced today that it has entered into an additional, long-term...
Spark Energy, Inc. Reports Third Quarter 2016 Financial Results and Raises 2016 Guidance
Nov 09, 2016 21:01 pm UTC| Business
HOUSTON, Nov. 09, 2016 -- Spark Energy, Inc. (NASDAQ:SPKE), a Delaware corporation ("Spark"), today reported financial results for the quarter ended September 30, 2016. Highlights Achieved $20.3 million in Adjusted...
Conifer Holdings Reports 2016 Third Quarter Financial Results
Nov 09, 2016 21:01 pm UTC| Business
BIRMINGHAM, Mich., Nov. 09, 2016 -- Conifer Holdings, Inc. (Nasdaq:CNFR) (“Conifer” or the “Company”) today announced results for the third quarter ended September 30, 2016. Third Quarter 2016 Highlights (all...
CareDx Reports Third Quarter 2016 Financial Results
Nov 09, 2016 21:01 pm UTC| Business
BRISBANE, Calif., Nov. 09, 2016 -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions...
CymaBay Reports Third Quarter 2016 Financial Results
Nov 09, 2016 21:01 pm UTC| Business
NEWARK, Calif., Nov. 09, 2016 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for indications with high unmet medical need, including rare and...